Evidence map›Paper›PMID 18443117›Full record

ArticleAntimicrobial agents and chemotherapy2008

Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.

Ian A Critchley, Michael R Jacobs, Steven D Brown, Maria M Traczewski, Glenn S Tillotson, Nebojsa Janjic

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 34 citations in OpenAlex.

  1. The oral penems and carbapenems.Clinical microbiology reviews · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Rhinosinusitis: evidence and experience. A summary.Brazilian journal of otorhinolaryngology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ian A CritchleyReplidyne Inc., 1450 Infinite Drive, Louisville, CO 80027, USA. icritchley@replidyne.com
Michael R Jacobs
Steven D Brown
Maria M Traczewski
Glenn S Tillotson
Nebojsa Janjic
Teledyne Technologies (United States) · USHuman BioMolecular Research Institute · USCase Western Reserve University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Of 393 isolates of Streptococcus pneumoniae from U.S. children collected in 2005-2006, nonvaccine serotypes accounted for 89.1%, with serotype 19A the most prevalent, representing 30.5% of all isolates. The MIC(90) of faropenem against serotype 19A isolates was 1 mug/ml, compared to > or =8 microg/ml against amoxicillin/clavulanate, cefdinir, cefuroxime axetil, and azithromycin.

Indexed as

AdolescentAnti-Bacterial Agentsbeta-LactamsChildChild, PreschoolDrug Resistance, BacterialHumansInfantMicrobial Sensitivity TestsPhenotypePneumococcal InfectionsSerotypingStreptococcus pneumoniaeUnited StatesAnti-Bacterial Agentsbeta-Lactamsfropenem

Identifiers

PMID18443117
PMCPMC2443873
OpenAlexW2153607742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.